Bangura Mohamed S, Zhao Yuqian, Gonzalez Mendez Maria Jose, Wang Yixuan, Didier Sama Salah, Xu Kunpeng, Ren Ran, Ma Li, Qiao You-Lin
School of Public Health, Dalian Medical University, Dalian, China.
Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Front Med (Lausanne). 2022 Sep 15;9:928685. doi: 10.3389/fmed.2022.928685. eCollection 2022.
Cervical cancer is a public health issue of global concern. It is a preventable disease but continues to threaten the lives of women, especially in developing countries in sub-Saharan Africa.
We selected two African countries in sub-Saharan Africa (the Republic of Rwanda and the Republic of Sierra Leone) to show a good example of cervical cancer prevention and constrains hindering countries from effectively implementing cervical cancer programs. Secondary data were collected from the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), the Global Burden of Cancer (GLOBOCAN), the United Nations Development Programme (UNDP), and the World Bank and from official websites of the selected countries. A descriptive analysis method was used to source data and compare variables such as the associated factors, disease burden, prevention programs, health workforce, success factors, and challenges.
Rwanda achieved 93.3% human papillomavirus (HPV) vaccination of the three doses vaccinating girls in class 6, as a result of effective school-based platform delivery system and community partnership to identify girls who are out of school. Rwanda reduced the historical two-decade gap in vaccine introduction between high- and low-income countries. The country also introduced a nationwide cervical cancer screening and treatment program. An impressive decreased cervical cancer incidence rate in Rwanda in recent years was observed. Sierra Leone lags behind in terms of almost all cervical cancer prevention programs. Therefore, Sierra Leone needs more efforts to implement cervical cancer intervention programs at the national level, including HPV vaccination, and train and increase the number of health professionals, treatment, and palliative care services to accelerate cervical cancer activities.
The disease burden of cervical cancer for Rwanda and Sierra Leone is heavy. There remains huge room for improvement in preventing and controlling cervical cancer in these countries. The goal of cervical cancer elimination would not be feasible in countries without the awareness and will of the policymakers and the public, the compliance to fund cervical cancer programs, the prioritization of cervical cancer activities, the availability of resources, the adequate health workforce and infrastructure, the cross-sectional collaboration and planning, inter-sectorial, national, regional, and international partnerships.
宫颈癌是一个全球关注的公共卫生问题。它是一种可预防的疾病,但仍继续威胁着女性的生命,尤其是撒哈拉以南非洲的发展中国家。
我们选择了撒哈拉以南非洲的两个国家(卢旺达共和国和塞拉利昂共和国),以展示宫颈癌预防的良好范例以及阻碍各国有效实施宫颈癌防治项目的制约因素。二手数据收集自世界卫生组织(WHO)、国际癌症研究机构(IARC)、全球癌症负担(GLOBOCAN)、联合国开发计划署(UNDP)、世界银行以及所选国家的官方网站。采用描述性分析方法来获取数据并比较相关因素、疾病负担、预防项目、卫生人力、成功因素和挑战等变量。
由于有效的校内平台输送系统以及社区合作以识别失学女童,卢旺达六年级女孩三剂人乳头瘤病毒(HPV)疫苗接种率达到了93.3%。卢旺达缩小了高收入和低收入国家在疫苗引入方面长达二十年的历史差距。该国还推出了全国性的宫颈癌筛查和治疗项目。近年来卢旺达宫颈癌发病率显著下降。塞拉利昂在几乎所有宫颈癌预防项目方面都滞后。因此,塞拉利昂需要在国家层面做出更多努力来实施宫颈癌干预项目,包括HPV疫苗接种,并培训和增加卫生专业人员数量、治疗及姑息治疗服务,以加速宫颈癌防治工作。
卢旺达和塞拉利昂的宫颈癌疾病负担沉重。这些国家在宫颈癌防控方面仍有很大的改进空间。如果没有政策制定者和公众的意识与意愿、对宫颈癌防治项目资金的合规投入、对宫颈癌防治活动的优先安排、资源的可得性、充足的卫生人力和基础设施、跨部门合作与规划以及部门间、国家、区域和国际伙伴关系,在这些国家消除宫颈癌的目标将无法实现。